TCT-17 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 3-Year Clinical and Imaging Results

Stefan Verheye,Joachim Schofer,Michael Maeng,Bernhard Witzenbichler,Roberto Botelho,John A. Ormiston,Ricardo A. Costa,Jose d Costa,Daniel Chamié,Juliana P. Castro,Andrea Abizaid,Yan John,Vinayak Bbhat,Lynn Morrison,Sara Toyloy,Alexandre Abizaid

Journal of the American College of Cardiology（2015）

引用 1|浏览22

暂无评分

摘要

The DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) is a drug-eluting bioresorbable scaffold combining a PLLA-based scaffold coated with a biodegradable polylactide-based polymer and Novolimus, a macrocyclic lactone mTOR inhibitor. The DESolve NX study is a prospective,

查看译文

关键词

Bioabsorbable scaffolds, Drug-eluting stent, bioabsorbable, Novolimus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要